# Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease

> **NCT02768077** · PHASE4 · UNKNOWN · sponsor: **Kuhnil Pharmaceutical Co., Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Melatonin(Circadin®)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02768077
- **Lead sponsor:** Kuhnil Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02768077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02768077, "Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02768077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*